• Accepting Children: No
• Accepting New Patients: Yes

• Accepting Medicare: Yes
• Accepting Medicaid/DSHS: Yes

Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Cash, Check, Money Order

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Internship: Robert Wood Johnson Hospital, NJ

An interventional cardiologist with the Swedish Heart and Vascular Institute since 1995, Dr. Reisman has been the principle investigator for a number of groundbreaking clinical trials. He is a national leader in development and initial application of several medical devices. He has authored books and manuscripts on several of these techniques, which have provided a roadmap for many other physicians to use these technologies effectively and safely.

Dr. Reisman has also played a key role in the Swedish Heart & Vascular Institute’s efforts to look at other technologies for opening arteries and keeping them open. He is renowned for his pioneering work in the developing field of neurocardiovascular interventions for the treatment and prevention of strokes as well as structural heart disease. These later studies will allow patients to have treatments to heart valves and other structures of their hearts using catheter based techniques that do not require open surgery.

Dr. Reisman earned a Bachelor’s degree from the State University of New York at Stony Brook and a medical degree from Sackler School of Medicine’s New York State program. He completed an internship in internal medicine at Robert Wood Johnson Hospital in New Brunswick, N.J., followed by a two-year residency in internal medicine and a two-year fellowship in cardiology at St. Luke’s Roosevelt Hospital in New York, N.Y. Most recently, he completed a fellowship in interventional cardiology from University of California San Diego Medical Center.

Board-certified in cardiology, Dr. Reisman has an additional certification in internal medicine. He is the Chief Scientific Officer and the Director of Cardiovascular Research and Education at Swedish Medical Center. Dr. Reisman has been a clinical associate professor of medicine at the University of Washington since 2009, and works collaboratively on investigational studies with the university. He is also president of the board of directors for the Seattle Science Foundation and the director of several cardiology programs throughout the country.

He maintains an active clinical practice and continues to lead research into new therapies in the Cardiovascular Cardiac catheterization laboratory.

Philosophy of Care

Dr. Reisman is passionate about creating an environment where both doctors and patients are partners, working together to create the best care possible.

Personal Interests

Dr. Reisman enjoys playing and watching sports, outdoor activities, and spending time with his family.

Medical School

Sackler School of Medicine, NY

Residency

St. Lukes Roosevelt Hospital, New York, NY

Fellowship(s)

UCSD Medical Center, San Diego, CA

Board Certifications

Board Certified in Cardiovascular Disease; Fellow, American College of Cardiology; Board Certified in Internal Medicine

Professional Associations:

American Medical Association, American College of Cardiology

Additional Information:

Internship: Robert Wood Johnson Hospital, NJ

An interventional cardiologist with the Swedish Heart and Vascular Institute since 1995, Dr. Reisman has been the principle investigator for a number of groundbreaking clinical trials. He is a national leader in development and initial application of several medical devices. He has authored books and manuscripts on several of these techniques, which have provided a roadmap for many other physicians to use these technologies effectively and safely.

Dr. Reisman has also played a key role in the Swedish Heart & Vascular Institute’s efforts to look at other technologies for opening arteries and keeping them open. He is renowned for his pioneering work in the developing field of neurocardiovascular interventions for the treatment and prevention of strokes as well as structural heart disease. These later studies will allow patients to have treatments to heart valves and other structures of their hearts using catheter based techniques that do not require open surgery.

Dr. Reisman earned a Bachelor’s degree from the State University of New York at Stony Brook and a medical degree from Sackler School of Medicine’s New York State program. He completed an internship in internal medicine at Robert Wood Johnson Hospital in New Brunswick, N.J., followed by a two-year residency in internal medicine and a two-year fellowship in cardiology at St. Luke’s Roosevelt Hospital in New York, N.Y. Most recently, he completed a fellowship in interventional cardiology from University of California San Diego Medical Center.

Board-certified in cardiology, Dr. Reisman has an additional certification in internal medicine. He is the Chief Scientific Officer and the Director of Cardiovascular Research and Education at Swedish Medical Center. Dr. Reisman has been a clinical associate professor of medicine at the University of Washington since 2009, and works collaboratively on investigational studies with the university. He is also president of the board of directors for the Seattle Science Foundation and the director of several cardiology programs throughout the country.

He maintains an active clinical practice and continues to lead research into new therapies in the Cardiovascular Cardiac catheterization laboratory.

Dr. Reisman is a board certified interventional cardiologist performing Coronary Artery Stenting and Carotid Artery Stenting. He is a recognized expert in the area of Structural Heart Disease therapies, with clinical interests focused on Percutaneous Aortic Valve Replacement, Aortic Balloon Valvuloplasty, and Percutaneous Mitral Valve Repair. Dr. Reisman also treats adult congenital heart disease, including Atrial Septal Defect and Patent Foramen Ovale (PFO) closure, as well as treatment of Patent Ductus Ateriosus and Ventricular Septal Defects. He also provides treatment for Atrial Fibrillation, including Percutaneous Left Atrial Appendage Ligation.

Dr. Reisman is renowned for his pioneering work in the developing field of neurocardiovascular interventions. He also participates in multiple clinical research trials in these therapeutic areas, which involve many new and emerging technologies. He believes that research is a key component to his clinical practice and believes that research trials are a vital offering to patients as it expands their care options.